Phase II failures: 2008–2010
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the decreasing success rate of drugs entering clinical trials (29) suggests that the pharmacology of target-based drug candidates predicts their therapeutic efficacy and toxicity poorly.”
From Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation (2013) · cites this paper as [29]
In the citing paper
“In the development of pharmaceutical drugs over 80% fail to reach ‘Phase III’ effectiveness trials, even after considerable investment [4].”
From Exploratory studies to decide whether and how to proceed with full-scale evaluations of public health interventions: a systematic review of guidance (2018) · cites this paper as [4]
Citations
Cites
Still being checked.
Cited by
Items 601–624 of 624
Early Development of Erenumab for Migraine Prophylaxis
Vargas, G. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_25
Insights into drug adverse reactions prediction through Mendelian randomization: a review
Huang, Z., Gong, H., Sun, X., Yi, W., Liang, S., Yang, S., Sun, Q., & Yan, X. (2025) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae203
Multiobjective optimization of biological and physical properties in drug discovery
Gleeson, M. P., & Montanari, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00014-5
Umar, Y. A., Shanono, U. U., Ozojiofor, U. O., & Egbe, N. E. (2025) · Journal of Umm Al-Qura University for Applied Sciences · doi:10.1007/s43994-025-00237-2
The Importance of Pharmacokinetics in Early Drug Discovery
Chen, E. P. (2025) · Wiley eBooks · doi:10.1002/9781119650263.ch01
Hartl, D., Suffiotti, M., Cornelisse, P., & Strasser, D. S. (2025) · Research Square · doi:10.21203/rs.3.rs-6993651/v1
Dai, Y., Tan, X., Wang, H., Ma, G., Xiong, Y., & Qiu, X. (2026) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109163
Erdmann, S., Kirchner, M., Götte, H., & Kieser, M. (2020) · Figshare · doi:10.6084/m9.figshare.13076697
Altunel, E., Roghani, R. S., Chen, K.-Y., Kim, S. Y., McCall, S. J., Ware, K. E., Shen, X., Somarelli, J. A., & Hsu, D. S. (2020) · Figshare · doi:10.6084/m9.figshare.12561008
Malik, V., Kalakoti, Y., & Sundar, D. (2021) · Figshare · doi:10.6084/m9.figshare.14299371
Animal Model Replacement Using AI Simulation: An Expanding Frontier in Biomedical Research
Verma, A., & Shrivastava, A. (2025) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v3i2.2025.195 · Cited by 1
Talukder, P., Nandi, A., Sengupta, S., Das, S., & Sultana, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814533126010005
Gu, Y., Geng, Z., Zhan, T., Henner, W. R., Wang, L., & Pulkstenis, E. P. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108291
Développement d'outils pour l'étude des interactions protéine-protéine
Milhas, S. (2016) · theses.fr (ABES) · doi:10.70675/7dcf6f45z231cz483fzb8f5z5cd27c8b0499
Accelerating Drug Discovery and Development: Harnessing AI for Enhanced Efficiency and Speed
Sajithabanu, S., Ramachandran, M. S., Anand, A. J., & Samundeeswari, K. (2026) · Springer eBooks · doi:10.1007/978-3-032-23626-5_13
Silverman, R. B., Xue, F., & Juncosa, J. I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15862-9.00003-5
Artificial intelligence enabled virtual screening
Kumar, S., & Gupta, M. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40338-5.00010-x
Basic aspects in biomedical research methodology
Khattab, M. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45595-7.00003-0
Asaduzzaman, M., Nahar, L., Biswas, M. S., & Rahman, M. M. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100887
Evaluation of Memory Enhancing Activity of different Herbs using Experimental Models
Sorate, P. P., Killedar, S. G., & Mule, R. A. (2026) · Asian Journal of Pharmaceutical Research · doi:10.52711/2231-5691.2026.00063
BindingDB (2016) · UC San Diego · doi:10.7270/q2154jq6
Allergy and Allergic Disorders: Homeopathic Leaders
Davidson, J. R. T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0527-0_10
Metadata
- Authors
- Arrowsmith, J.
- Affiliations
- Thomson Reuters (United Kingdom) (GB)
- Corresponding author
- Arrowsmith, John
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-04-29
- Volume
- 10
- Issue
- 5
- Pages
- 328-329
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2065540447
- Cited by
- 622
- References
- 0
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 22 · 2023: 14 · 2022: 21 · 2021: 25 · 2020: 36 · 2019: 44 · 2018: 37 · 2017: 54 · 2016: 64 · 2015: 66 · 2014: 66 · 2013: 88 · 2012: 41
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- drug development failure, clinical trial attrition, drug repurposing, translational research
- MeSH terms
- Drug Industry, Pharmaceutical Preparations, Humans, Drug Design, Treatment Failure, Clinical Trials, Phase II as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.